Company / SG&A per Share
PLUS THERAPEUTICS, INC. SG&A per Share History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.69
FY2025
5-year range
$0.04 / $1.92
FY2021-FY2025
Trend
-12.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share has fluctuated over the past 10 years, ranging from $0.04 in FY2017 to $1.92 in FY2024.
Based on SEC 10-K filings.
1.69 in FY2025 with a 10-year CAGR of +26.4%.
Increased from $1.31 to $1.69 over the past 7 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +26.4%
Key checks
Key Insights
- In FY2025, sg&a per share decreased 12.3% year-over-year.
- Peak sg&a per share was recorded in FY2024.
- Lowest sg&a per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -2.46 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.69 | -12.3% |
| FY2024 | $1.92 | +46.4% |
| FY2018 | $1.31 | +2967.3% |
| FY2017 | $0.04 | -94.3% |
| FY2016 | $0.75 | +365.4% |
| FY2015 | $0.16 | -26.6% |
| FY2014 | $0.22 | -1.6% |
| FY2013 | $0.22 | +0.6% |
| FY2012 | $0.22 | +10.8% |
| FY2011 | $0.20 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026